GLAXOSMITHKLINE, manufacturer of Panadol, Lucozade to end operations in Nigeria

READ ALSO:. SEE full list of 47 MINISTERIAL NOMINEES and States of Origin at a glance

BRITISH Pharmaceutical giant company, GlaxoSmithKline (GSK) has announced plans to end its prescription medicines and vaccines in the country after 51 years of operations in Nigeria.

In a statement sent to the Nigerian Exchange Limited, the multinational pharmaceutical company said it would transition to a third-party direct distribution model for its pharmaceutical products.

At the same time, the company said it is now working with its advisers to agree on the next steps, while it plans to submit a scheme of arrangements to the Securities and Exchange Commission for the possible return of cash to its local shareholders.

READ ALSO:.  NIGERIAN Longest Reigning Monarch: HRH Oba Aladesuru, Onigede of Igede Ekiti Marks 64 Years on Throne (Story By Abiodun Omole)

GlaxoSmithKiline was incorporated in Nigeria in June 1971 and commenced business the following year.

The multinational pharmaceutical company, initially known as Beecham at its incorporation, is well-known for products like Panadol, Ribena, Lucozade, Macleans, and Andrews Liver Salt, among other products.

READ ALSO:.  TROOPS waste bandits, rescue victims,  destroy criminal hideouts in three states (SEE PHOTOS)